{
    "title": "Livzon Pharma's COVID vaccine gets approval as booster in China",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11173611/China-approves-Livzon-Pharmas-COVID-vaccine-new-products-year.html",
    "date": "2022-09-02",
    "keywords": [
        "booster",
        "vaccine",
        "omicron",
        "sinovac",
        "use",
        "sinopharm",
        "dose",
        "livzon",
        "disease",
        "country",
        "year",
        "pfizerbiontech",
        "moderna",
        "ba5",
        "vaccination",
        "variant",
        "trial",
        "emergency",
        "authorisation",
        "group",
        "company",
        "coronavirus",
        "public",
        "population",
        "ba4",
        "canada",
        "uk",
        "data",
        "antibody",
        "mixandmatch",
        "technology",
        "one",
        "risk",
        "covid19",
        "journal",
        "efficacy",
        "analysis",
        "paper",
        "bivalent",
        "subvariant",
        "yang",
        "manager",
        "unit",
        "mabpharm",
        "health",
        "event",
        "roxanne",
        "liu",
        "woo",
        "editing",
        "jason",
        "jane",
        "merriman"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}